The public's acceptance of novel vaccines during a pandemic: a focus group study and its application to influenza H1N1
2009

Public Acceptance of Novel Vaccines During a Pandemic

Sample size: 85 publication Evidence: moderate

Author Information

Author(s): N Henrich, B Holmes

Primary Institution: Centre for Health Evaluation and Outcome Sciences - St Paul“s Hospital

Hypothesis

What influences a person's decision to get vaccinated with a novel vaccine in the event of a pandemic?

Conclusion

The study found that public acceptance of novel vaccines during a pandemic is influenced by perceptions of risk and concerns about vaccine safety.

Supporting Evidence

  • Participants expressed concerns about the safety of new vaccines developed rapidly during a health crisis.
  • Many participants felt they would not be at risk of infection when the disease was still confined to its country of origin.
  • Parents were more likely to vaccinate themselves than their children due to concerns about long-term effects.

Takeaway

People are worried about getting new vaccines during a pandemic because they don't trust that they are safe and they think they might not get sick.

Methodology

The study used focus groups to gather qualitative data from the public about their perceptions and attitudes towards novel vaccines.

Potential Biases

Participants were mainly female, which may reflect how households respond to an EID pandemic.

Limitations

The focus group participants are not representative of all members of the population, and the results are not generalizable.

Participant Demographics

Participants included university students, adult Canadians from various backgrounds, parents, and health-care workers.

Digital Object Identifier (DOI)

10.3134/ehtj.09.008

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication